Amundi’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-343,512
| Closed | -$10.5M | – | 2035 |
|
|
2025
Q1 | $10.5M | Sell |
343,512
-63,416
| -16% | -$1.94M | ﹤0.01% | 821 |
|
|
2024
Q4 | $33M | Sell |
406,928
-27,864
| -6% | -$2.26M | 0.01% | 639 |
|
|
2024
Q3 | $48.6M | Sell |
434,792
-7,516
| -2% | -$840K | 0.02% | 551 |
|
|
2024
Q2 | $33.7M | Buy |
442,308
+139,951
| +46% | +$10.7M | 0.01% | 610 |
|
|
2024
Q1 | $18.3M | Sell |
302,357
-27,431
| -8% | -$1.66M | 0.01% | 715 |
|
|
2023
Q4 | $20M | Sell |
329,788
-13,124
| -4% | -$797K | 0.01% | 717 |
|
|
2023
Q3 | $15.8M | Buy |
342,912
+80,311
| +31% | +$3.69M | 0.01% | 746 |
|
|
2023
Q2 | $12.9M | Buy |
+262,601
| New | +$12.9M | 0.01% | 790 |
|
|
2022
Q4 | – | Sell |
-2,604
| Closed | -$62K | – | 1951 |
|
|
2022
Q3 | $62K | Hold |
2,604
| – | – | ﹤0.01% | 1630 |
|
|
2022
Q2 | $64K | Buy |
+2,604
| New | +$64K | ﹤0.01% | 1513 |
|
|
2022
Q1 | – | Sell |
-5,795
| Closed | -$115K | – | 1684 |
|
|
2021
Q4 | $115K | Buy |
+5,795
| New | +$115K | ﹤0.01% | 1552 |
|